The impact of cytokines in neuroinflammation-mediated stroke
Sneha Kumari,
No information about this author
Rishika Dhapola,
No information about this author
Prajjwal Sharma
No information about this author
et al.
Cytokine & Growth Factor Reviews,
Journal Year:
2024,
Volume and Issue:
78, P. 105 - 119
Published: July 2, 2024
Language: Английский
Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes
Journal of Functional Biomaterials,
Journal Year:
2025,
Volume and Issue:
16(1), P. 8 - 8
Published: Jan. 1, 2025
Each
year,
the
number
of
cases
strokes
and
deaths
due
to
this
is
increasing
around
world.
This
could
be
work
stress,
lifestyles,
unhealthy
food
habits,
several
other
reasons.
Currently,
there
are
traditional
methods
like
thrombolysis
mechanical
thrombectomy
for
managing
strokes.
The
current
approach
has
limitations,
delayed
diagnosis,
limited
therapeutic
delivery,
risks
secondary
injuries.
So,
a
need
some
effective
reliable
management
strokes,
which
help
in
early
diagnosis
followed
by
treatment
Nanotechnology
played
an
immense
role
recently,
it
emerged
as
transformative
solution
offering
innovative
diagnostic
tools
strategies.
Nanoparticles
(NPs)
belonging
classes,
including
metallic
(metallic
metal
oxide),
organic
(lipids,
liposome),
carbon,
can
cross
blood–brain
barrier
may
exhibit
potential
various
Moreover,
these
NPs
have
exhibited
promise
improving
imaging
specificity
delivery
precise
drug
real-time
monitoring
efficacy.
Nanomaterials
cerium
oxide
(CeO2)
liposome-encapsulated
agents
neuroprotective
properties
that
reduce
oxidative
stress
promote
neuroregeneration.
In
present
article,
authors
emphasized
significant
advancements
nanomedicine
stroke,
NPs-based
systems,
neuroregenerative
therapies,
multimodal
advancements.
Language: Английский
MST1, a novel therapeutic target for Alzheimer's disease, regulates mitochondrial homeostasis by mediating mitochondrial DNA transcription and the PI3K-Akt-ROS pathway
Dongqing Cui,
No information about this author
Haixia Liu,
No information about this author
Lili Cao
No information about this author
et al.
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Nov. 22, 2024
Alzheimer's
disease
(AD)
is
a
prevalent
irreversible
neurodegenerative
condition
marked
by
gradual
cognitive
deterioration
and
neuronal
loss.
The
mammalian
Ste20-like
kinase
(MST1)–Hippo
pathway
pivotal
in
regulating
cell
apoptosis,
immune
response,
mitochondrial
function,
oxidative
stress.
However,
the
association
between
MST1
function
AD
remains
unknown.
Therefore,
this
study
investigates
effect
of
on
damage
impairment
homeostasis
AD.
In
study,
4-
7-month-old
5xFAD
mice
were
selected
to
simulate
early
middle
stages
AD,
respectively;
age-matched
wild-type
served
as
controls
for
comparative
analysis.
Adeno-associated
virus
(AAV)
was
injected
into
hippocampus
mice.
Four
weeks
post-injection,
indicators,
morphology,
dynamics,
stress,
ATP,
apoptosis-related
indicators
evaluated.
Additionally,
RNA-sequencing
performed
hippocampal
tissue
MST1-knockdown
Subsequently,
Gene
Ontology
(GO)
enrichment
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
analyses
differentially
expressed
genes
elucidate
potential
mechanism
MST1.
vitro
studies
investigate
effects
SH-SY5Y
model
viability
validate
underlying
molecular
mechanisms.
overexpression
accelerated
degeneration
deficits
vivo
while
promoting
stress
damage.
Similarly,
vitro,
facilitated
apoptosis
dysfunction.
knockdown
chemical
inactivation
reduced
decline,
dysfunction,
degeneration.
Mechanistically,
regulated
transcription
genes,
including
MT-ND4L,
MT-ATP6,
MT-CO2,
binding
PGC1α.
Moreover,
influenced
cellular
through
PI3K-Akt-ROS
pathway,
ultimately
disrupting
mediating
Cumulatively,
these
results
suggest
that
primarily
regulates
DNA
levels
interacting
with
PGC1α
modulates
homeostasis.
This
discovery
can
be
exploited
potentially
enhance
energy
metabolism
pathways
targeting
MST1,
offering
novel
therapeutic
targets
treating
Language: Английский
Exploring therapeutical targets and innovative treatments for ischemic stroke: a comprehensive review
Exploration of Neuroprotective Therapy,
Journal Year:
2024,
Volume and Issue:
unknown, P. 459 - 484
Published: Nov. 20, 2024
This
review
focuses
on
the
current
advances
in
field
of
therapeutic
targets
and
treatments
for
stroke.
Stroke
is
a
major
health
problem
worldwide,
with
significant
impacts
morbidity
mortality,
considerable
burden
medical
socio-economic
systems.
provides
comprehensive
overview
state
knowledge
acute
targets.
Current
stroke
like
recanalization
therapies
focus
mainly
restoring
blood
flow
to
brain,
reducing
cell
death,
preventing
further
damage,
but
have
limitations
terms
efficacy
long-term
outcomes.
Besides
(mobile
units,
telerehabilitation)
targets,
longer-term
such
as
neuroprotection
neuroregeneration.
Neuroprotective
strategies
target
mechanisms
underlying
energy
failure,
cellular
acidosis,
mitochondrial
dysfunction,
endoplasmic
reticulum
stress,
excitotoxicity,
calcium
channels
dysregulation,
oxidative
neuroinflammation,
blood-brain
barrier
disruption,
apoptosis,
ischemia-reperfusion
injury.
Neuroregenerative
approaches
include
stem
therapy,
gene
growth
factors,
rehabilitation
techniques
that
promote
rewiring
neuronal
circuits
brain.
Non-pharmacological
neurostimulation
bioengineering
are
also
presented.
Additionally,
we
highlight
challenges
future
directions
translating
these
into
clinical
practice.
Overall,
treatment
ischemic
complex
multifaceted
process
requires
combination
measures
well
brain
repair
recovery.
The
has
made
progress
recent
years
development
new
ongoing
research
improve
outcomes
patients.
However,
before
can
be
successfully
integrated
routine
practise,
needed
establish
standardised
protocols,
overcome
methodological
limitations,
challenges.
By
deepening
our
understanding
pathophysiology
developing
innovative
treatments,
quality
life
survivors.
Language: Английский
MAM-mediated mitophagy and endoplasmic reticulum stress: the hidden regulators of ischemic stroke
Ziyi Jia,
No information about this author
Hongtao Li,
No information about this author
Ke Xu
No information about this author
et al.
Frontiers in Cellular Neuroscience,
Journal Year:
2024,
Volume and Issue:
18
Published: Nov. 21, 2024
Ischemic
stroke
(IS)
is
the
predominant
subtype
of
and
a
leading
contributor
to
global
mortality.
The
mitochondrial-associated
endoplasmic
reticulum
membrane
(MAM)
specialized
region
that
facilitates
communication
between
mitochondria,
has
been
extensively
investigated
in
context
neurodegenerative
diseases.
Nevertheless,
its
precise
involvement
IS
remains
elusive.
This
literature
review
elucidates
intricate
MAM
mitophagy
stress
during
IS.
PINK1,
FUNDC1,
Beclin1,
Mfn2
are
highly
concentrated
play
crucial
role
regulating
mitochondrial
autophagy.
GRP78,
IRE1,
PERK,
Sig-1R
participate
unfolded
protein
response
(UPR)
within
MAM,
Hence,
diverse
molecules
on
operate
independently
interact
with
each
other,
collectively
contributing
pathogenesis
as
covert
orchestrator.
Language: Английский
Silencing lncRNA GABPB1-AS1 alleviates cerebral ischemia reperfusion injury through the miR-641/NUCKS1 axis
American Journal of Translational Research,
Journal Year:
2024,
Volume and Issue:
16(7), P. 2963 - 2972
Published: Jan. 1, 2024
To
investigate
the
possible
mechanism
of
lncRNA
GA
binding
protein
transcription
factor
beta
subunit
1
antisense
RNA
(GABPB1-AS1)
in
cerebral
ischemia/reperfusion
(CI/R)
injury.
Language: Английский